IASO Biotherapeutics Publishes Preclinical Results of Its CD5-Targeting CAR-T in American Society of Gene & Cell Therapy’s Journal, Molecular Therapy
PLEASANTON, Calif. & NANJING, China & SHANGHAI--(BUSINESS WIRE)--#Biopharmaceutical--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company…